Login / Signup

Insight on Non-Coding RNAs from Biofluids in Ovarian Tumors.

Yohann DabiAmélia FavierLeo RazakamanantsoaLéa DelbosMathieu PoilblancPhilippe DescampsFrancois GolfierCyril TouboulSofiane BendifallahEmile Daraï
Published in: Cancers (2023)
Ovarian tumors are the most frequent adnexal mass, raising diagnostic and therapeutic issues linked to a large spectrum of tumors, with a continuum from benign to malignant. Thus far, none of the available diagnostic tools have proven efficient in deciding strategy, and no consensus exists on the best strategy between "single test", "dual testing", "sequential testing", "multiple testing options" and "no testing". In addition, there is a need for prognostic tools such as biological markers of recurrence and theragnostic tools to detect women not responding to chemotherapy in order to adapt therapies. Non-coding RNAs are classified as small or long based on their nucleotide count. Non-coding RNAs have multiple biological functions such as a role in tumorigenesis, gene regulation and genome protection. These ncRNAs emerge as new potential tools to differentiate benign from malignant tumors and to evaluate prognostic and theragnostic factors. In the specific setting of ovarian tumors, the goal of the present work is to offer an insight into the contribution of biofluid non-coding RNAs (ncRNA) expression.
Keyphrases
  • squamous cell carcinoma
  • polycystic ovary syndrome
  • adipose tissue
  • pregnant women
  • clinical practice
  • insulin resistance
  • climate change
  • binding protein
  • free survival
  • long non coding rna